Published in PLoS One on March 28, 2017
Cancer-related inflammation. Nature (2008) 34.21
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell (2004) 15.82
NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol (2005) 13.98
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell (2009) 11.52
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 11.22
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell (2009) 6.26
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest (2008) 5.26
The consensus molecular subtypes of colorectal cancer. Nat Med (2015) 4.35
Syndecans: new kids on the signaling block. Circ Res (2005) 2.43
Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev (2009) 2.35
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet (2000) 2.23
IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep (2009) 2.14
Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut (1996) 2.06
Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem (2000) 2.01
Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol (2010) 1.93
The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell (2011) 1.92
The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol (2004) 1.91
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene (2010) 1.88
Syndecans in inflammation. FASEB J (2003) 1.84
IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle (2005) 1.79
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem (2008) 1.74
Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci (2002) 1.72
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell (2013) 1.71
Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? Cell Div (2010) 1.70
Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation. Cell (2010) 1.67
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut (2009) 1.65
Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell (2012) 1.55
The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol (2009) 1.53
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest (2008) 1.52
Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol (2014) 1.52
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood (2002) 1.50
Molecular functions of syndecan-1 in disease. Matrix Biol (2011) 1.47
Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol (2005) 1.38
Colon cancer--understanding how NSAIDs work. N Engl J Med (2006) 1.32
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. J Clin Invest (2011) 1.32
Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J Biol Chem (2004) 1.20
Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J Biol Chem (2010) 1.16
Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation (2007) 1.13
Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest Ophthalmol Vis Sci (2002) 1.11
Emerging cytokine networks in colorectal cancer. Nat Rev Immunol (2015) 1.09
Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol (2013) 1.09
Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int (2007) 1.05
Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice. Am J Pathol (2009) 1.04
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer. Oncology (2005) 1.03
Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors. BMC Cancer (2008) 0.98
Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J Immunol (2009) 0.98
Heparan sulfate signaling in cancer. Trends Biochem Sci (2014) 0.97
Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J Biol Chem (2008) 0.97
Origin and deposition of basement membrane heparan sulfate proteoglycan in the developing intestine. J Cell Biol (1989) 0.94
Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig Dis Sci (1999) 0.93
Immunolocalization of extracellular matrix components during organogenesis in the human small intestine. Anat Embryol (Berl) (1991) 0.93
Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis. Blood (2004) 0.91
Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice. Biochem Pharmacol (2012) 0.90
Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease. Inflamm Bowel Dis (2013) 0.89
Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases. Int J Med Sci (2015) 0.86
Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis. J Immunol (2013) 0.86
Immunohistochemical localization of heparan sulfate proteoglycan in human gastrointestinal tract. Histochem Cell Biol (2001) 0.86
Low molecular weight heparin relieves experimental colitis in mice by downregulating IL-1β and inhibiting syndecan-1 shedding in the intestinal mucosa. PLoS One (2013) 0.83
Carbohydrate-containing molecules as potential biomarkers in colon cancer. OMICS (2014) 0.81
Syndecan-1 and Its Expanding List of Contacts. Adv Wound Care (New Rochelle) (2015) 0.80
Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease. Int J Colorectal Dis (2005) 0.80
Expression of heparan sulfate proteoglycans in murine models of experimental colitis. Inflamm Bowel Dis (2011) 0.79
Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease. Gastroenterol Res Pract (2015) 0.79
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine. Oncotarget (2015) 0.76
Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis. BMC Gastroenterol (2015) 0.76
Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis. J Pharmacol Exp Ther (2011) 0.76
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget (2015) 0.94
Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy. FEBS J (2016) 0.80
Heparanase interacts with resistin and augments its activity. PLoS One (2014) 0.77
Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat (2016) 0.76
CX3CR1hi Monocyte/Macrophages Support Bacterial Survival and Experimental Infection-Driven Bone Resorption. J Infect Dis (2015) 0.75
Inhibition of Myeloid Differentiation Factor 88 Reduces Human and Mouse T-Cell Interleukin-17 and IFNγ Production and Ameliorates Experimental Autoimmune Encephalomyelitis Induced in Mice. Front Immunol (2017) 0.75